NL960017I2 - Expressie van Factor VIII-activiteit in zoogdiercellen. - Google Patents

Expressie van Factor VIII-activiteit in zoogdiercellen.

Info

Publication number: NL960017I2
Authority: NL; Netherlands
Prior art keywords: factor; nucleotide sequence; proteins; expression; mammalian cells
Prior art date: 1985-04-17

Application number

NL960017C

Other languages

English (en)

Other versions

NL960017I1 (nl

Original Assignee

Zymogenetics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-04-17

Filing date

1996-07-09

Publication date

1997-02-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24909926&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL960017(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-07-09 Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc

1996-10-01 Publication of NL960017I1 publication Critical patent/NL960017I1/nl

1997-02-03 Publication of NL960017I2 publication Critical patent/NL960017I2/nl

Links

230000000694 effects Effects 0.000 title abstract 2
102000001690 Factor VIII Human genes 0.000 title 1
108010054218 Factor VIII Proteins 0.000 title 1
229960000301 factor viii Drugs 0.000 title 1
210000004962 mammalian cell Anatomy 0.000 title 1
102100022641 Coagulation factor IX Human genes 0.000 abstract 4
108010076282 Factor IX Proteins 0.000 abstract 4
229960004222 factor ix Drugs 0.000 abstract 4
239000002773 nucleotide Substances 0.000 abstract 4
125000003729 nucleotide group Chemical group 0.000 abstract 4
108010054265 Factor VIIa Proteins 0.000 abstract 3
229940012414 factor viia Drugs 0.000 abstract 3
102000004169 proteins and genes Human genes 0.000 abstract 3
108090000623 proteins and genes Proteins 0.000 abstract 3
230000004071 biological effect Effects 0.000 abstract 2
230000023555 blood coagulation Effects 0.000 abstract 2
102000005701 Calcium-Binding Proteins Human genes 0.000 abstract 1
108010045403 Calcium-Binding Proteins Proteins 0.000 abstract 1
102100023804 Coagulation factor VII Human genes 0.000 abstract 1
108010023321 Factor VII Proteins 0.000 abstract 1
108010022999 Serine Proteases Proteins 0.000 abstract 1
102000012479 Serine Proteases Human genes 0.000 abstract 1
230000003197 catalytic effect Effects 0.000 abstract 1
229940012413 factor vii Drugs 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/644—Coagulation factor IXa (3.4.21.22)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NL960017C 1985-04-17 1996-07-09 Expressie van Factor VIII-activiteit in zoogdiercellen. NL960017I2 (nl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US72431185A	1985-04-17	1985-04-17

Publications (2)

Publication Number	Publication Date
NL960017I1 NL960017I1 (nl)	1996-10-01
NL960017I2 true NL960017I2 (nl)	1997-02-03

Family

ID=24909926

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL960017C NL960017I2 (nl)	1985-04-17	1996-07-09	Expressie van Factor VIII-activiteit in zoogdiercellen.

Country Status (4)

Country	Link
US (1)	US8603777B1 (nl)
NL (1)	NL960017I2 (nl)
RU (1)	RU2122583C1 (nl)
ZA (1)	ZA862768B (nl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT409379B (de)	1999-06-02	2002-07-25	Baxter Ag	Medium zur protein- und serumfreien kultivierung von zellen
EP1982732A3 (en) *	2000-02-11	2011-06-08	Bayer HealthCare LLC	Factor VII or VIIA-like conjugates
EP1216709A1 (en) *	2000-12-21	2002-06-26	Boehringer Ingelheim Pharma KG	Use of activated coagulation factor VII for treating thrombolytic therapy-induced major bleedings
RU2321633C2 (ru) *	2001-02-16	2008-04-10	Ново Нордиск Хелт Кэр Аг	Способ получения витамин к-зависимых белков
IL157842A0 (en) *	2001-03-22	2004-03-28	Novo Nordisk Healthcare Ag	Coagulation factor vii derivatives
HK1080372A1 (zh) *	2002-05-01	2006-04-28	Schering Aktiengesellschaft	作为抗凝剂的新型组织因子目标抗体
RU2262947C2 (ru) *	2002-07-24	2005-10-27	Общество с ограниченной ответственностью фирма "Технология-Стандарт"	Способ получения тромбиноподобного коагулирующего фермента
RU2331072C2 (ru) *	2003-03-03	2008-08-10	Ланг Флориан	sgk1 В КАЧЕСТВЕ ДИАГНОСТИЧЕСКОЙ И ТЕРАПЕВТИЧЕСКОЙ МИШЕНИ
AU2004221758B2 (en) *	2003-03-18	2010-07-22	Novo Nordisk Health Care Ag	Method for the production of GLA-residue containing serine proteases
US7897734B2 (en)	2003-03-26	2011-03-01	Novo Nordisk Healthcare Ag	Method for the production of proteins
DK1644504T3 (da) *	2003-06-19	2010-05-25	Bayer Healthcare Llc	Faktor VII- eller -VIIA-Gla-domænevarianter
GB0324044D0 (en) *	2003-10-14	2003-11-19	Astrazeneca Ab	Protein
RU2271219C1 (ru) *	2004-07-28	2006-03-10	Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова Министерства здравоохранения Российской Федерации"	Способ получения тромбиноподобных ферментов из яда змеи
RU2396086C2 (ru) *	2004-09-10	2010-08-10	Фармаоригин Апс	Способы лечения трахеального, бронхиального или альвеолярного кровотечения или кровохарканья
RU2448160C1 (ru) *	2010-11-11	2012-04-20	Закрытое акционерное общество "ГЕНЕРИУМ"	РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pAP271, КОДИРУЮЩАЯ ПОЛИПЕПТИД ФАКТОРА VII СВЕРТЫВАЕМОСТИ КРОВИ ЧЕЛОВЕКА, И ЛИНИЯ КЛЕТОК Mesocricetus auratus ВНК 21 k.13 (2H7) - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ФАКТОРА VII СВЕРТЫВАЕМОСТИ КРОВИ ЧЕЛОВЕКА

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4399216A (en) *	1980-02-25	1983-08-16	The Trustees Of Columbia University	Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4459288A (en)	1981-05-11	1984-07-10	Baxter Travenol Laboratories, Inc.	Therapeutic blood clotting factor compositions and their use
US4382083A (en)	1981-06-25	1983-05-03	Baxter Travenol Laboratories, Inc.	Therapeutic method for treating blood-clotting defects with factor VIIa
US4456591A (en) *	1981-06-25	1984-06-26	Baxter Travenol Laboratories, Inc.	Therapeutic method for activating factor VII
GR860984B (en) *	1985-04-17	1986-08-18	Zymogenetics Inc	Expression of factor vii and ix activities in mammalian cells
GB2215409A (en) *	1988-02-29	1989-09-20	Deere & Co	Seals for bearings in baling machines
EP1774017B1 (en) *	2004-07-26	2013-05-15	Pfenex Inc.	Process for improved protein expression by strain engineering

1986
- 1986-04-14 ZA ZA862768A patent/ZA862768B/xx unknown
- 1986-04-16 RU SU4027461A patent/RU2122583C1/ru active
1991
- 1991-09-25 US US07/765,452 patent/US8603777B1/en active Active
1996
- 1996-07-09 NL NL960017C patent/NL960017I2/nl unknown

Also Published As

Publication number	Publication date
ZA862768B (en)	1986-12-30
NL960017I1 (nl)	1996-10-01
RU2122583C1 (ru)	1998-11-27
US8603777B1 (en)	2013-12-10

Similar Documents

Publication	Publication Date	Title
ATE92105T1 (de)	1993-08-15	Expression von faktor-vii-aktivitaet in saeugetierzellen.
NL960017I1 (nl)	1996-10-01	Expressie van Factor VIII-activiteit in zoogdiercellen.
JPS6485096A (en)	1989-03-30	Hybrid human protein c and biotechnological synthesis thereof
DK0624199T3 (da)	1999-11-01	Fremgangsmåder til fremstilling af thrombin
UA32548C2 (uk)	2001-02-15	Ізольована послідовність днк, що кодує epsps фермент, ізольована послідовність днк, що кодує білок, який виявляє epsps активність, рекомбінантна двониткова молекула днк, спосіб одержання генетично трансформованих рослин
ES8705521A1 (es)	1987-05-01	Un metodo de producir un polipetido similar a factor de necrosis de tumores (tnf) de mamiferos.
DE3786321D1 (de)	1993-07-29	Expression von protein-c.
DE69131580D1 (de)	1999-10-07	GDF-1 und UOG1 Proteine
DE69121391D1 (de)	1996-09-19	Methode zur ortsspezifischen änderung von rna und produktion von dadurch kodierten polypeptiden
ATE319818T1 (de)	2006-03-15	Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
DE60033138D1 (de)	2007-03-15	Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
DE69942861D1 (de)	2010-11-25	Ldcam genannte moleküle
ATE414775T1 (de)	2008-12-15	Polypeptide mit prolyldipeptidylaminopeptidase- aktivität und dafür kodierende nukleinsäuren
DK288183D0 (da)	1983-06-22	Fremgangsmade til fremstilling af et oligonucleotidt terapeutisk middel
HUT46061A (en)	1988-09-28	Dna sequences encoding hirudin-like protein and process for producing such proteins
DE69837475D1 (de)	2007-05-16	Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
PT84089B (pt)	1989-02-28	Sequencias de adn codificando para proteinas possuindo a actividade biologica dos inibidores de husi-tipo i, processos biotecnologicos para a preparacao das referidas proteinas e de composicoes farmaceuticas contendo as referidas proteinas
ATE105480T1 (de)	1994-05-15	Thrombin bindende substanz und verfahren zu ihrer herstellung.
ATE211390T1 (de)	2002-01-15	Überlegende thrombomodulinanaloga zur pharmazeutischen verwendung
DE3650477D1 (de)	1996-03-14	Produktion von Cystinreste enthaltenden aktiven Proteinen
IT1186750B (it)	1987-12-16	Vettore di clonaggio,molecole di dna ricombinante,ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni